Retrospective Treatment Pattern Survey for the Patients With Hypertension and Stroke - Full Text View

Sponsored by:	AstraZeneca
Information provided by:	AstraZeneca
ClinicalTrials.gov Identifier:	NCT00681707

Purpose

This study will address the treatment rate and control rate of hypertension, treatment pattern and factors that affect BP control by examining retrospective medical records of hypertension patients recovering from stroke, among outpatients coming to the Neurology Department in 10 university hospitals nationwide.

Condition
Hypertension

MedlinePlus related topics: High Blood Pressure

U.S. FDA Resources

Study Type:	Observational
Study Design:	Cohort, Retrospective
Official Title:	A Retrospective, Multi Centre, Non-Interventional, Observational Study to Investigate Treatment Pattern of Blood Pressure in the Post Stroke Patients With Hypertension.

Further study details as provided by AstraZeneca:

Primary Outcome Measures:

Attainment rate to the target blood pressure [ Time Frame: After collecting all Patient Record Form. ] [ Designated as safety issue: No ]

Secondary Outcome Measures:

Dropout rate will be estimated during the follow-up period after the hypertension treatment. Attainment to the target blood pressure will be investigated according to concomitant diseases. [ Time Frame: After collecting all Patient Record Form. ] [ Designated as safety issue: No ]
Change in DBP/SBP value during the follow-up period will be addressed. Change in the DBP/SBP value will be investigated according to the risk factors and concurrent disease. [ Time Frame: After collecting all Patient Record Form. ] [ Designated as safety issue: No ]

Biospecimen Retention: None Retained

Biospecimen Description:

Estimated Enrollment:	1000
Study Start Date:	May 2008
Estimated Study Completion Date:	December 2008

Groups/Cohorts
1 Hypertension patients recovering from stroke

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No
Sampling Method:	Non-Probability Sample

Study Population

Patient with history of stroke, receiving hypertension medication during at least 1 year.

Criteria

Inclusion Criteria:

Patients had been hospitalized as a acute stroke in 2006
Patient with history of stroke receiving hypertension medication during at least 1 year.

Exclusion Criteria:

Secondary hypertension patients
Patients not receiving hypertension medication

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00681707

Locations

Korea, Republic of
Research Site
Busan, Korea, Republic of
Research Site
Deagu, Korea, Republic of
Research Site
Deajeon, Korea, Republic of
Research Site
Kwangju, Korea, Republic of
Research Site
Seoul, Korea, Republic of
Korea, Republic of, Gyeonggi
Research Site
Goyang, Gyeonggi, Korea, Republic of
Research Site
Sungnam, Gyeonggi, Korea, Republic of
Korea, Republic of, Kangwon
Research Site
Wonju, Kangwon, Korea, Republic of

Sponsors and Collaborators

AstraZeneca

Investigators

Study Director:

Joon Woo Bahn

Astrazenca Korea medical dept.

More Information

Responsible Party:	AstraZeneca ( Joonwoo Bahn )
Study ID Numbers:	NIS-CKR-DUM-2008/1
Study First Received:	May 19, 2008
Last Updated:	October 9, 2008
ClinicalTrials.gov Identifier:	NCT00681707
Health Authority:	Korea: Food and Drug Administration

Keywords provided by AstraZeneca:

Hypertension
Post stroke
JNC7
2007 ESH-ESC guidelines
survey

Study placed in the following topic categories:

Cerebral Infarction
Stroke
Vascular Diseases
Hypertension

Additional relevant MeSH terms:

Cardiovascular Diseases

ClinicalTrials.gov processed this record on January 14, 2009